source
- Retrospective Data Show Potential Real-World TTNT and OS Improvements With Next-Generation BTK Inhibitors in R/R MCLRetrospective data showed zanubrutinib was associated with improved real-world overall survival vs ibrutinib in second- or third-line mantle cell lymphoma.onclive · 2mo ago↗ source
- STAT+: Trump pivots on kratom derivative 7-OH, floating approval for some formsLast year, the FDA had warned that natural opioids in kratom were being turned into harmful products. Now President Trump says approval should be considered.STAT · 2mo ago↗ source
- STAT+: Medicare’s miss on Alzheimer’s drug spendingFar fewer seniors than expected are taking costly Alzheimer's drugs.STAT